ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment

Zhou, Huanhuan; Wang, Ping; Qin, Xian; Zhang, Xing*; Lai, Keng Po*; Chen, Jian*1
Food & Function2023-6-19DOI: 10.1039/d2fo03962a
5阅读
引用收藏
分享

摘要

Bladder cancer is one of the most common cancers worldwide, with 213 000 deaths reported in 2020. Patients with a progression from non-muscle-invasive bladder cancer to muscle-invasive disease have poorer prognosis and survival rates. Therefore, there is an urgent need to identify novel drugs to prevent the recurrence and metastasis of bladder cancer. Formononetin is an active compound extracted from the herb Astragalus membranaceus that possesses anticancer properties. Few studies have demonstrated the anti-bladder cancer effects of formononetin; however, the detailed mechanism remains unknown. In this study, we used two bladder cancer cell lines, TM4 and 5637, to investigate the potential role of formononetin in bladder cancer treatment. Comparative transcriptomic analysis was conducted to delineate the molecular mechanisms underlying the anti-bladder cancer effects of formononetin. Our results showed that formononetin treatment inhibited the proliferation and colony-forming abilities of bladder cancer cells. Additionally, formononetin reduced the migration and invasion of bladder cancer cells. Transcriptomic analysis further highlighted the involvement of formononetin-mediated two clusters of genes involved in endothelial cell migration (FGFBP1, LCN2, and STC1) and angiogenesis (SERPINB2, STC1, TNFRSF11B, and THBS2). Taken together, our results suggest the potential use of formononetin to inhibit the recurrence and metastasis of bladder cancer through the regulation of different oncogenes.

学科与关键词

关键词
BREAST-CANCERCELL-PROLIFERATIONDRUG-RESISTANCESTC1 EXPRESSIONTUMOR-GROWTHMETASTASISACTIVATIONMIGRATIONINVASIONKINASE
相关
加载中…
  • Properties of flavonoids in the treatment of bladder cancer (Review)
    Lv, Yue; Liu, Zhonghao; Jia, Haixing; Xiu, Youcheng; Liu, Zan; Deng, LeihongExperimental and Therapeutic Medicine, 2022, 24(5): 676.被引 5
  • Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
    Chen, Lizhi; Zhou, Yue; Weng, Zheng; Liu, Shuang; Li, Ting; Wang, Yanfang; Yang, Yang; Liu, Hongmei*; Huang, Wenhua*Aging-US, 2023, 15(20): 11489-11507.
  • Natural Phytochemicals in Bladder Cancer Prevention and Therapy
    Xia, Yong*; Chen, Ruijiao; Lu, Guangzhen; Li, Changlin; Lian, Sen; Kang, Taek-Won; Jung, Young Do*Frontiers in Oncology, 2021, 11: 652033.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
Food & Function
发表日期
2023-06-19
卷期
第 14 卷, 第 12 期
页码
5787-5804
DOI
10.1039/d2fo03962a
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of Guangxi Province [2019GXNSFFA245001, 2020GXNSFAA259044]; National Natural Science Foundation of China [81973574, 82060736, 82160282]

作者

  • Z

    Zhou, Huanhuan (第一作者)

    guilin med univ · 1

  • W

    Wang, Ping

    guilin med univ · 1

查看全部 6 位作者收起作者
  • Q

    Qin, Xian

  • Z

    Zhang, Xing (通讯)

    guilin med univ · 1

  • L

    Lai, Keng Po (通讯)

    guilin med univ · 1

  • C

    Chen, Jian (通讯)

    guilin med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417